A Drug & Medical Device Recall And/Or Safety Alert Has Been Issued: Vitaflo USA Renastart: Recall – Possible Health Risk Due To Incorrectly Labeled Cans. According to the Food & Drug Administration FDA’s MedWatch:
Consequences of using the incorrectly labeled product may result in high potassium blood levels (hyperkalemia) or high sodium levels in the blood (hypernatremia).
For more information on the drug or medical device recall or safety alert, read the Food & Drug Administration’s FDA’s drug or medical device recall or safety alert: Vitaflo USA Renastart: Recall – Possible Health Risk Due To Incorrectly Labeled Cans.
To report an adverse reaction, problem or other issue with a drug or medical device, submit a drug or medical device complaint to the government at fda.gov or MedWatch.
If you have thoughts on the drug or medical device recall or safety alert, share your drug or medical device recall or safety alert comments below.